Mitochondrial DNA damage in a mouse model of alzheimer's disease decreases amyloid beta plaque formation

42Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mitochondrial DNA (mtDNA) damage and the generation of reactive oxygen species have been associated with and implicated in the development and progression of Alzheimer's disease. To study how mtDNA damage affects reactive oxygen species and amyloid beta (Aβ) pathology invivo, we generated an Alzheimer's disease mouse model expressing an inducible mitochondrial-targeted endonuclease (Mito-. PstI) in the central nervous system. Mito-. PstI cleaves mtDNA causing mostly an mtDNA depletion, which leads to a partial oxidative phosphorylation defect when expressed during a short period in adulthood. We found that a mild mitochondrial dysfunction in adult neurons did not exacerbate Aβ accumulation and decreased plaque pathology. Mito-. PstI expression altered the cleavage pathway of amyloid precursor protein without increasing oxidative stress in the brain. These data suggest that mtDNA damage is not a primary cause of Aβ accumulation. © 2013 Elsevier Inc.

Cite

CITATION STYLE

APA

Pinto, M., Pickrell, A. M., Fukui, H., & Moraes, C. T. (2013). Mitochondrial DNA damage in a mouse model of alzheimer’s disease decreases amyloid beta plaque formation. Neurobiology of Aging, 34(10), 2399–2407. https://doi.org/10.1016/j.neurobiolaging.2013.04.014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free